Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-000846-32Phase 3Active
Phase 3, randomised trial of citalopram and levodopa in brain infarction and ischemic stroke (3 arms), sponsored by Hospital General Universitari de Granollers. Primary endpoints: Functional outcome at 12 months, Neurological severity and 2 more. Started Sep 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-000846-32.